A 56-year-old woman with established type 2 diabetes (HbA1c 8.5% on maximal metformin) and obesity has normal eGFR and no history of cardiovascular di...

Question

A 56-year-old woman with established type 2 diabetes (HbA1c 8.5% on maximal metformin) and obesity has normal eGFR and no history of cardiovascular disease. According to Diabetes Canada pharmacologic management guidance, what is the most appropriate next step?

Accepted Answer

Add an SGLT2 inhibitor or GLP-1 receptor agonist with proven cardiovascular benefit

Answer

Add a sulfonylurea as second-line therapy

Answer

Switch metformin to basal insulin

Answer

Stop metformin and start pioglitazone

Answer

Rely on lifestyle changes only and recheck HbA1c in 1 year

ca-mccqe1 MCQ (SBA): Type 2 diabetes pharmacologic management

A 56-year-old woman with established type 2 diabetes (HbA1c 8.5% on maximal metformin) and obesity has normal eGFR and no history of cardiovascular disease. According to Diabetes Canada pharmacologic management guidance, what is the most appropriate next step?